ArticleBMC cancer2013

Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study.

Zsuzsanna Varga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.